Skip to main content
. 2021 Jun 15;51(11):e13624. doi: 10.1111/eci.13624

FIGURE 3.

FIGURE 3

Therapeutic target of pharmacological treatment in patients with heart failure with reduced ejection fraction. ACEi and ARBs should be prescribed when ARNi are not tolerated. ACEi, ACE inhibitor; ARBs, Angiotensin II receptor blockers; ARNi, angiotensin receptor neprilysin inhibitor; HFrEF, heart failure with reduced ejection fraction; HR, heart rate; MRA, mineralocorticoid receptor antagonists; SGLT2i, sodium‐glucose cotransporter‐2 inhibitor